{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"STML-401-0423 A Phase II Multicenter Open-Label Trial of Tagraxofusp (TAG) in Combination with Venetoclax and Azacitadine (VEN\/AZA) in Adults with Previously Untreated CD123+ Acute Myeloid Leukemia (AML) who are Ineligible for Intensive Chemotherapy","item":"https:\/\/www.regionalcancercare.org\/trials\/stml-401-0423-a-phase-ii-multicenter-open-label-trial-of-tagraxofusp-tag-in-combination-with-venetoclax-and-azacitadine-ven-aza-in-adults-with-previously-untreated-cd123-acute-myeloid-leukemia-a\/#breadcrumbitem"}]}